Retinopathy of prematurity (ROP) is a condition of retina which affects premature newborns with low birth weight. Two risk factors for ROP are associated systemic illnesses and high concentration of oxygen which is usually given to premature babies.
A company based in Bengaluru, India ‘Forus Health’ has developed an imaging system which they call as ‘3nethra Neo’. This is a hand-held and easy-to-use device to detect cases of retinopathy of prematurity.
“There is no moving part, so transportation becomes easy and secondly, since there is no motor, the size becomes more compact and everything is built-in the device. The only thing you have outside the device is the power supply and laptop,” said Chandrasekhar.
3nethra Neo was designed alongside the initial sales of 3nethra Classic, the company’s flagship adult retinal imaging device that has been deployed in 25 countries. “The challenge really was while we are operationalising one product, we were investing in R&D and time on another product,” said Chandrasekhar. 3nethra is one-fourth the cost of the presently available product.